| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 1689 |
| 1 | ADALIMUMAB | 1687 |
| 2 | DICLOFENAC SODIUM | 1681 |
| 3 | RITUXIMAB | 1675 |
| 4 | SECUKINUMAB | 1662 |
| 5 | DICLOFENAC | 1618 |
| 6 | LEFLUNOMIDE | 1608 |
| 7 | METHOTREXATE | 1605 |
| 8 | PREDNISONE | 1513 |
| 9 | ALENDRONATE SODIUM | 1492 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE BUTYRATE | 291 | 0.1473 |
| 1 | CAFFEINE CITRATE | 298 | 0.1277 |
| 2 | DICLOFENAC POTASSIUM TABLETS | 983 | 0.1134 |
| 3 | GOLIMUMAB | 1365 | 0.1084 |
| 4 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 69 | 0.1049 |
| 5 | NICOTINAMIDE | 241 | 0.0943 |
| 6 | TRIPROLIDINE HYDROCHLORIDE | 18 | 0.0923 |
| 7 | PSEUDOEPHEDRINE HCL | 992 | 0.0906 |
| 8 | DICLOFENAC POTASSIUM | 983 | 0.0889 |
| 9 | CORTISONE ACETATE | 980 | 0.0784 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2056 |
| 1 | Corticosteroid [EPC] | 1961 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 1838 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 1713 |
| 4 | Vitamin C [EPC] | 1672 |
| 5 | Interleukin-17A Antagonist [EPC] | 1668 |
| 6 | Antirheumatic Agent [EPC] | 1608 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 1605 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 1523 |
| 9 | Vitamin B12 [EPC] | 1510 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 733 | 1.0654 |
| 1 | Endoglycosidase [EPC] | 200 | 0.1079 |
| 2 | Interleukin-17A Antagonist [EPC] | 1668 | 0.0447 |
| 3 | Provitamin D2 Compound [EPC] | 1130 | 0.0380 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 271 | 0.0311 |
| 5 | Antirheumatic Agent [EPC] | 1608 | 0.0152 |
| 6 | Aminosalicylate [EPC] | 1485 | 0.0147 |
| 7 | beta3-Adrenergic Agonist [EPC] | 658 | 0.0138 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 1523 | 0.0110 |
| 9 | Histamine-1 Receptor Antagonist [EPC] | 914 | 0.0108 |